Next Article in Journal
Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma
Next Article in Special Issue
Synergistic Antitumor Activity of Talazoparib and Temozolomide in Malignant Rhabdoid Tumors
Previous Article in Journal
Intratumoral Delivery of Interleukin 9 via Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in Tumor Models
Previous Article in Special Issue
PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma
 
 
Review

Article Versions Notes

Cancers 2024, 16(5), 1022; https://doi.org/10.3390/cancers16051022
Action Date Notes Link
article pdf uploaded. 29 February 2024 17:54 CET Version of Record https://www.mdpi.com/2072-6694/16/5/1022/pdf-vor
article xml file uploaded 1 March 2024 09:52 CET Original file -
article xml uploaded. 1 March 2024 09:52 CET Update https://www.mdpi.com/2072-6694/16/5/1022/xml
article pdf uploaded. 1 March 2024 09:52 CET Updated version of record https://www.mdpi.com/2072-6694/16/5/1022/pdf
article html file updated 1 March 2024 09:53 CET Original file https://www.mdpi.com/2072-6694/16/5/1022/html
Back to TopTop